🇺🇸 FDA
Patent

US 7514434

Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof

granted A61PA61P31/00

Quick answer

US patent 7514434 (Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P31/00